Antibiotic-Resistant propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%

Cutis

Volumn 82, Issue 6, 2008, Pages 417-421

  Leyden, James J ^a,b   Wortzman, Mitchell ^b   Baldwin, Edward K ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Medicis Pharmaceutical Corporation   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; DERMATOLOGICAL AGENT; DETERGENT;

ADULT; ARTICLE; BACTERIAL COUNT; CLINICAL TRIAL; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE; PROPIONIBACTERIUM ACNES; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; COLONY COUNT, MICROBIAL; DERMATOLOGIC AGENTS; DETERGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PROPIONIBACTERIUM ACNES; TIME FACTORS;

EID: 60749100036     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Leyden JJ, McGinley KJ, Cavalieri S, et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol. 1983;8:41-45.
2. Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol. 1989;121:51-57.
3. Cooper AJ. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust. 1998;169:259-261.
4. Dreno B, Reynaud A, Moyse D, et al. Erythromycin- resistance of cutaneous bacterial flora in acne. Eur J Dermatol. 2001;11:549-553.
5. Tan HH, Goh CL, Yeo MG, et al. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore. Ann Acad Med Singapore. 2001 ;30: 22-25.
6. Ross JI, Snelling AM, Eady EA, et al. Pheno-typic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol. 2001; 144: 339-346.
7. Coates P, Vyakrnam S, Eady EA, et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146:840-848.
8. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic resistant acne: lessons from Europe. Br J Dermatol. 2003;148:467-478.
9. Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet. 2004;364: 2188-2195.
10. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003 ;49 (suppl 1):S1-S37.
11. Bojar RA, Cunliffe WJ, Holland KT. The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermatol. 1995;132:204-208.
12. Eady EA, Farmery MR, Ross JI, et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol. 1994;131: 331-336.
13. Eady EA, Bojar RA, Jones CE, et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol. 1996;134: 107-113.
14. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol. 1997; 37:590-595.
15. Cunliffe WJ, Holland KT, Bojar R, et al. A randomized, double-blind comparison of a clindamycin phosphate/ benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002;24:1117-1133.
16. Gans EH, Kligman AM. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes. J Dermatolog Treat. 2002;13: 107-110.
17. Keyworth N, Millar MR, Holland KT. Swab-wash method for quantitation of cutaneous microflora. J Clin Microbiol. 1990;28:941-943.
18. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007;79(suppl 6):9-25.
19. Leyden J. New developments in topical antimicrobial therapy for acne. J Drugs Dermatol. 2008;7(suppl 2): S8-S11.
20. Data on file. Scottsdale, AZ: Medicis Pharmaceutical Corporation; 2007.
21. Tschen E, Jones T. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin. J Drugs Dermatol. 2002;1:153-157.
22. Triaz (benzoyl peroxide) 6% cleanser [package insert]. Scottsdale, AZ: Medicis, The Dermatology Company; 2005.
23. Weinberg JM. The utility of benzoyl peroxide in hydro-phase base (Brevoxyl) in the treatment of acne vulgaris. J Drugs Dermatol. 2006;5:344-349.